Keywords: LDS; Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
مقالات ISI LDS (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: LDS; Short rotation woody crops; Willow biomass; Planting operations; Field capacity; Planting stock; BCAP; Biomass Crop Assistance Program; Cf; field capacity; FS; Cf at field speed; FSD; Cf in field including delay time; GPS; global positioning system; HLD;
Development of human biotransformation QSARs and application for PBT assessment refinement
Keywords: LDS; In vivo biotransformation; Biotransformation half-life; QSAR; Hazard assessment; Refined PBT assessment; 1-CoPK; one-compartment pharmacokinetic model; AD; Applicability Domain; ADME; Absorption, Distribution, Metabolism and Elimination; B; Bioaccumulati
A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice
Keywords: LDS; Mucosal vaccines; Nanoemulsion; IL-17 Responses; Ag85B; Antigen 85B; ANOVA; Analysis of variance; BCG; Mycobacterium bovis bacillus Calmette-Guerin; BCIP/NBT; 5-Bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolium chloride; C; Centigrade; C57BL/6J;
Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity
Keywords: LDS; Nasal vaccine strategy; secretory IgA; reverse transcytosis; microfold cells; nasal-associated lymphoid tissue; protection; DC; Dendritic cell; DC-SIGN; Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin; HLT; Heat-labile t
Massively parallel computing and the search for jets and black holes at the LHC
Keywords: LDS; ATLAS; CMS; HLT; Tracker system; Jets; Black holes;
The ALICE data acquisition system
Keywords: LDS; Data acquisition; LHC; ALICE; CERN; ACT; ALICE configuration tool; AMORE; Automatic MOnitoRing Environment; API; application programming interface; BIST; Built-In Self-Test; CASTOR; CERN Advanced STORage manager; CTP; central trigger processor; CVS; concu
A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic
Keywords: LDS; AE; adverse event; AESI; adverse event of special interest; CHMP; Committee for Medicinal Products for Human Use; EMA; European Medicines Agency; HLT; High Level Term; PT; Preferred Term; SAE; serious adverse event; SOC; System Organ Class; WHO; World Hea
Comparison of Outcomes From Smoking and Nonsmoking Donors: Thirteen-Year Experience
Keywords: LDS; BLT; bilateral lung transplant; BOS; bronchiolitis obliterans; CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; CVA; cerebrovascular accident; Emp; emphysema; HLT; heart lung transplantation; LTX; lung transplantation; NSmD; nonsmoking do
The ALICE TPC, a large 3-dimensional tracking device with fast readout for ultra-high multiplicity events
Keywords: LDS; AC; alternating current; ACORDE; ALICE COsmic ray DEtector; ADC; analog to digital converter; ALEPH; apparatus for LEP PHysics; ALICE; a large ion collider experiment; ALTRO; ALICE TPC ReadOut chip; BC; board controller; CAD; computer aided design; CAN; c
Determinants of financial distress and bankruptcy in highly levered transactions
Keywords: LDS; Bankruptcy; Financial distress; HLT; Levered buyouts; Levered recapitalizations
Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants
Keywords: LDS; Human papillomavirus type 16; Virus-like particles; HLT; CpG ODN; Mucosal immunization; Antibody and cell-mediated immune responses